Masimo Corporation
MASI
Κατάταξη σε μετοχές
#2169
Masimo Corporation engages in the development, manufacture, and marketing of... Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
Τιμή μετοχής
$179.95
Τελευταίος συγχρονισμός: 2026-06-12
Κεφαλαιοποίηση
$9.42B
Αλλαγή (1 ημέρα)
0.00%
Αλλαγή (1 έτος)
22.41%
Χώρα
US
Εμπόριο Masimo Corporation (MASI)
Κατηγορία
Healthcare
Κέρδη για την Masimo Corporation (MASI)
Κέρδη τον Apr 2026 TTM: $275.60M
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της Masimo Corporation, τα τρέχοντα κέρδη της εταιρείας είναι $275.60M. Το 2023, η εταιρεία παρουσίασε κέρδη $88.10M, μείωση σε σύγκριση με των κερδών του 2022 που ήταν $193.40M. Τα κέρδη που εμφανίζονται σε αυτή τη σελίδα είναι πριν από τόκους και φόρους, γνωστά και ως EBIT.
Ιστορικό κερδών για την Masimo Corporation από 2002 έως 2026
Κέρδη στο τέλος κάθε έτους
| Έτος | Κέρδη | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $275.60M | -190.27% |
| 2024 | $-305.30M | -446.54% |
| 2023 | $88.10M | -54.45% |
| 2022 | $193.40M | -29.52% |
| 2021 | $274.40M | 4.06% |
| 2020 | $263.70M | 12.61% |
| 2019 | $234.17M | 9.54% |
| 2018 | $213.78M | 15.06% |
| 2017 | $185.80M | -57.14% |
| 2016 | $433.52M | 272.61% |
| 2015 | $116.35M | 14.02% |
| 2014 | $102.04M | 34.75% |
| 2013 | $75.73M | -9.66% |
| 2012 | $83.82M | -3.13% |
| 2011 | $86.53M | -19.56% |
| 2010 | $107.57M | 30.89% |
| 2009 | $82.18M | 13.52% |
| 2008 | $72.39M | 6.27% |
| 2007 | $68.12M | -78.33% |
| 2006 | $314.40M | 4,166.56% |
| 2005 | $7.37M | 0.00% |
| 2004 | 0.00 | -100.00% |
| 2003 | $-6.89M | 3,707.73% |
| 2002 | $-181.00K | 0.00% |
Κέρδη παρόμοιων εταιρειών ή ανταγωνιστών
| Εταιρεία | Κέρδη | Διαφορά Κερδών | Χώρα |
|---|---|---|---|
| $7.51B | 2,625.33% |
US
|
|
| $5.56B | 1,918.51% |
IE
|
|
| $5.15B | 1,767.92% |
US
|
|
| $3.86B | 1,300.94% |
US
|
|
| - | - |
DE
|
